在基于人群的短暂性脑缺血发作和缺血性卒中队列中对大出血风险评分的外部验证
在基于人群的OXVASC队列2072例服用抗血小板药的短暂性脑缺血发作或缺血性卒中患者中,外部验证S2TOP-BLEED评分,并与REACH和Intracranial-B2LEED3S评分比较。随访8302患者年,117例发生大出血。S2TOP-BLEED评分对大出血的C统计量为0.69(95%CI 0.64-0.73),3年大出血风险校准准确;对致死性出血的预测优于非大出血。
要点
- S2TOP-BLEED评分在基于人群队列中区分度中等,C统计量0.69,3年大出血风险校准准确。
- S2TOP-BLEED对致死性出血的C统计量为0.77,对非大出血为0.50。
- 缺血事件与出血的比值从低危组6.6:1降至高危组1.8:1。
核心结论
- S2TOP-BLEED评分在基于人群的短暂性脑缺血发作或缺血性卒中患者队列中表现中等。
- 出血风险与缺血事件风险相关,但风险分层可能仍有助于识别出血风险特别高的患者亚组,在该亚组中预防措施是有指征的。
研究设计与样本
- 在基于人群的OXVASC(牛津血管研究)队列中,研究2072例服用抗血小板药的短暂性脑缺血发作或缺血性卒中患者的出血风险。
- 根据S2TOP-BLEED、REACH和Intracranial-B2LEED3S三种评分进行评估。
- 采用C统计量和校准图评估评分表现。
主要发现
- 随访8302患者年期间,117例患者发生大出血。
- S2TOP-BLEED评分对大出血的C统计量为0.69(95%CI 0.64-0.73),对3年大出血风险校准准确。
- S2TOP-BLEED评分对致死性出血的C统计量为0.77(95%CI 0.69-0.85),对非大出血的C统计量为0.50(95%CI 0.44-0.58)。
- REACH评分对大出血的C统计量为0.63(95%CI 0.58-0.69)。
- Intracranial-B2LEED3S评分对颅内出血的C统计量为0.60(95%CI 0.51-0.70)。
关键数值与推荐
- S2TOP-BLEED评分对大出血的C统计量为0.69(95%CI 0.64-0.73)。
- S2TOP-BLEED评分对致死性出血的C统计量为0.77(95%CI 0.69-0.85),对非大出血的C统计量为0.50(95%CI 0.44-0.58)。
- REACH评分对大出血的C统计量为0.63(95%CI 0.58-0.69)。
- Intracranial-B2LEED3S评分对颅内出血的C统计量为0.60(95%CI 0.51-0.70)。
- 缺血事件与出血的比值从低危组的6.6:1降至高危组的1.8:1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The S2TOP-BLEED score may help to identify patients at high risk of bleeding on antiplatelet drugs after a transient ischemic attack or ischemic stroke. The score was derived on trial populations, and its performance in a real-world setting is unknown. We aimed to externally validate the S2TOP-BLEED score for major bleeding in a population-based cohort and to compare its performance with other risk scores for bleeding. METHODS: We studied risk of bleeding in 2072 patients with a transient ischemic attack or ischemic stroke on antiplatelet agents in the population-based OXVASC (Oxford Vascular Study) according to 3 scores: S2TOP-BLEED, REACH, and Intracranial-B2LEED3S. Performance was assessed with C statistics and calibration plots. RESULTS: During 8302 patient-years of follow-up, 117 patients had a major bleed. The S2TOP-BLEED score showed a C statistic of 0.69 (95% confidence interval [CI], 0.64-0.73) and accurate calibration for 3-year risk of major bleeding. The S2TOP-BLEED score was much more predictive of fatal bleeding than nonmajor bleeding (C statistics 0.77; 95% CI, 0.69-0.85 and 0.50; 95% CI, 0.44-0.58). The REACH score had a C statistic of 0.63 (95% CI, 0.58-0.69) for major bleeding and the Intracranial-B2LEED3S score a C statistic of 0.60 (95% CI, 0.51-0.70) for intracranial bleeding. The ratio of ischemic events versus bleeds decreased across risk groups of bleeding from 6.6:1 in the low-risk group to 1.8:1 in the high-risk group. CONCLUSIONS: The S2TOP-BLEED score shows modest performance in a population-based cohort of patients with a transient ischemic attack or ischemic stroke. Although bleeding risks were associated with risks of ischemic events, risk stratification may still be useful to identify a subgroup of patients at particularly high risk of bleeding, in whom preventive measures are indicated.
引用
- Hilkens NA, Li L, Rothwell PM, et al. External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients. Stroke. 2018. PMID: 29459399. doi:10.1161/STROKEAHA.117.019259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。